Published in Medical Letter on the CDC and FDA, June 14th, 2009
"The study was conducted at 13 sites. A noninferiority design with a 1:1 randomization was used. SAMPLE: Two hundred nine patients were randomized and treated (106 ACDF; 103...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.